# Abhishek Ramkumar

> Abhishek Ramkumar is the founder and CEO of Abram Scientific, a Menlo Park medtech company building CoagCare, a handheld point-of-care platform that reads the full blood-clotting story from a single drop in under ten minutes. A biomedical engineer with a PhD from Cornell and a B.Tech from IIT Bombay, he spent years at PARC and Blue Highway inventing diagnostic and surgical devices before turning a hard physics problem - measuring blood viscoelasticity and density in a vibration-proof wireless meter - into 17 granted patents and an $11.75M Series A led by Octapharma in 2026. His pitch is simple and life-or-death: get the right transfusion to the right patient at the right time, whether that patient is on an operating table or in a MEDEVAC helicopter.

- **Role:** Founder & CEO at Abram Scientific
- **Organizations:** Abram Scientific, Palo Alto Research Center (PARC), Blue Highway (Welch Allyn)
- **From:** India
- **Nationality:** Indian-American
- **Education:** B.Tech, Electrical Engineering, Indian Institute of Technology Bombay (IIT Bombay), M.S., Biomedical Engineering, Cornell University, Ph.D., Biomedical Engineering, Cornell University
- **Known for:** Founded Abram Scientific and invented its core CoagCare technology, Holds 17 granted U.S. and international patents protecting the platform, Raised $11.75M Series A led by Octapharma AG (Feb 2026); ~$15.1M total funding

## Career timeline

- **—** — Earned B.Tech in Electrical Engineering at IIT Bombay
- **—** — Completed M.S. and Ph.D. in Biomedical Engineering at Cornell University
- **—** — Evaluated physics and biophysics research concepts for startup financing at Blue Highway (Welch Allyn)
- **—** — Led biomedical diagnostics and drug-delivery research at Palo Alto Research Center (PARC)
- **—** — Founded Abram Scientific and invented the CoagCare point-of-care coagulation platform
- **2021** — Abram Scientific secured a $1M NSF SBIR Phase II grant
- **2024** — Presented 'Precision Blood Coagulation Management' at LSI USA '24 Emerging Medtech Summit
- **2026** — Closed $11.75M Series A led by Octapharma AG with University of Colorado Anschutz investors

## Achievements

- Founded Abram Scientific and invented its core CoagCare technology
- Holds 17 granted U.S. and international patents protecting the platform
- Raised $11.75M Series A led by Octapharma AG (Feb 2026); ~$15.1M total funding
- Won a $1M NSF SBIR Phase II grant
- Over 15 years inventing medical diagnostic and surgical devices

## Latest updates

- **2026-02** — Abram Scientific closed an $11.75M Series A led by Octapharma AG to advance CoagCare toward FDA 510(k) clearance and clinical milestones.

## Links

- Website: https://abramscientific.com
- LinkedIn: http://www.linkedin.com/in/abhishekramkumar
- Twitter/X: https://twitter.com/AbramScientific
- YouTube: https://www.youtube.com/watch?v=anghkkuki6s

---

Profile page: https://yespress.io/abhishek-ramkumar
Published by YesPress — https://yespress.io
Last updated: 2026-06-20